Peptron KRX:087010KOSDAQ

펩트론 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days8
DART filings, 7 days0
Articles tracked121since Sep 11

In Q2 2026, Peptron reported revenue of ₩1.4bn, up 1.4% year on year, and an operating loss of ₩7.9bn. Peptron (펩트론) appeared in 8 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Oct 22 with 7 articles. The most common catalyst was contracts & orders (3). It was most often mentioned alongside Yuhan, ABL Bio and OliX Pharmaceuticals.

Filing signals 4 quarters of losses Screener

Peptron quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩1.4bn+1.4%−₩7.9bn−₩7.7bn
Q1 2026₩2.0bn+21.4%−₩5.8bn
margin −293.8%
−₩6.1bn
Q4 2025 derived₩987m-36.1%−₩5.7bn−₩4.7bn
Q3 2025₩1.6bn+172.3%−₩6.2bn−₩2.0bn
Q2 2025₩1.4bn+163.0%−₩5.0bn−₩3.8bn
Q1 2025₩1.6bn+239.5%−₩4.4bn
margin −268.6%
−₩3.3bn
Q4 2024 derived₩1.5bn+93.2%−₩3.5bn
margin −227.4%
−₩5.0bn
Q3 2024₩588m-13.9%−₩4.7bn−₩4.8bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Peptron top stories 2 weeks, by number of outlets

  1. 1
    펩트론, 유한양행과 40억 기술이전 계약 해지…실제 수령액은 10억
    2 outlets · 2 articlesFirst report Oct 22 15:17 조선비즈Licensing dealYuhan
  2. 2
  3. 3
  4. 4
  5. 5
    펩트론, 유한양행과 15년 만에 'PT302' 기술이전 계약 해지…왜?
    1 outlets · 1 articlesFirst report Oct 22 06:52 이데일리Licensing dealYuhan
  6. 6
    펩트론 주가, 10월 20일 장중 99,800원 0.99% 하락
    1 outlets · 1 articlesFirst report Oct 20 14:04 중앙이코노미뉴스

Latest Peptron news Korean headlines